Literature DB >> 22253465

Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues.

Lawrence J Solin.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22253465     DOI： 10.1200/JCO.2011.39.6929

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment.

Authors:  Jing Luo; Brian S Johnston; Averi E Kitsch; Daniel S Hippe; Larissa A Korde; Sara Javid; Janie M Lee; Sue Peacock; Constance D Lehman; Savannah C Partridge; Habib Rahbar
Journal:  Radiology       Date:  2017-09-14       Impact factor: 11.105

Review 2.  Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.

Authors:  Nita Amornsiripanitch; Diana L Lam; Habib Rahbar
Journal:  Semin Roentgenol       Date:  2018-08-30       Impact factor: 0.800

3.  Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

Authors:  Habib Rahbar; Sana Parsian; Diana L Lam; Brian N Dontchos; Nicole K Andeen; Mara H Rendi; Constance D Lehman; Savannah C Partridge
Journal:  Clin Imaging       Date:  2015-07-26       Impact factor: 1.605

4.  DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast.

Authors:  R Souchon; M-L Sautter-Bihl; F Sedlmayer; W Budach; J Dunst; P Feyer; R Fietkau; W Haase; W Harms; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2014-01       Impact factor: 3.621

5.  Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention.

Authors:  Niamh Buckley; David Boyle; Darragh McArt; Gareth Irwin; D Paul Harkin; Tong Lioe; Stephen McQuaid; Jacqueline A James; Perry Maxwell; Peter Hamilton; Paul B Mullan; Manuel Salto-Tellez
Journal:  Oncotarget       Date:  2015-12-22

6.  Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype.

Authors:  M Lazzeroni; A Guerrieri-Gonzaga; E Botteri; M C Leonardi; N Rotmensz; D Serrano; C Varricchio; D Disalvatore; A Del Castillo; F Bassi; G Pagani; A DeCensi; G Viale; B Bonanni; G Pruneri
Journal:  Br J Cancer       Date:  2013-04-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.